Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1

16 Oct 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Genetic Neurodegenerative Diseases
Share to RNA Research and Splicing

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 27839685
DOI: 10.1016/j.bmcl.2016.10.037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1PMID 27839685Read ↗

A chemoinformatics-guided platform for efficient discovery of RNA-binding small molecules: Proof-of-concept for myotonic dystrophy type 1Semantic proximity Read ↗

Myotonic dystrophy: candidate small molecule therapeuticsSemantic proximity Read ↗

A small molecule that binds an RNA repeat expansion stimulates its decay via the exosome complexSemantic proximity Read ↗

Mitigating RNA Toxicity in Myotonic Dystrophy using Small MoleculesSemantic proximity Read ↗

Physicochemical Principles Driving Small Molecule Binding to RNASemantic proximity Read ↗

Therapeutics development in myotonic dystrophy type 1Semantic proximity Read ↗

Small molecule targeting of RNA structures in neurological disordersSemantic proximity Read ↗

RNA-targeted drugs for neuromuscular diseasesSemantic proximity Read ↗

Possibilities and challenges of small molecule organic compounds for the treatment of repeat diseasesSemantic proximity Read ↗

A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control PathwaysSemantic proximity Read ↗

Targeting RNA in mammalian systems with small molecules.Semantic proximity Read ↗

NMR structures and magnetic force spectroscopy studies of small molecules binding to models of an RNA CAG repeat expansionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.